Results 21 to 30 of about 145,000 (257)
BackgroundWe aim to evaluate the four surrogate markers of insulin resistance (IR), including triglyceride-glucose index (TyG), lipid accumulation product index (LAP), visceral adiposity index (VAI), triglycerides to high-density lipoprotein cholesterol ...
Yumeng Shi +21 more
doaj +1 more source
The usefulness of information on HDL-cholesterol: potential pitfalls of conventional assumptions
Treatment decisions related to disease prevention are often based on two conventional and related assumptions. First, an intervention-induced change in a surrogate marker (such as high-density lipoprotein [HDL]-cholesterol) in the desired direction ...
Furberg Curt D
doaj +1 more source
Evaluation of longitudinal surrogate markers
AbstractThe use of surrogate markers to examine the effectiveness of a treatment has the potential to decrease study length and identify effective treatments more quickly. Most available methods to investigate the usefulness of a surrogate marker involve restrictive parametric assumptions and tend to focus on settings where the surrogate is measured at
Denis Agniel, Layla Parast
openaire +4 more sources
Surrogate Sonographic Markers of Atherosclerosis [PDF]
To the Editor: We read with interest the work of Staub and coworkers for the comparison of internal carotid artery resistive index (RI) with the common carotid artery intima-media thickness in the prediction of cardiovascular morbidity and mortality.
Abbas, Mohammed Abdalla +1 more
openaire +3 more sources
Surrogate Adiposity Markers and Mortality
ImportanceBody mass index (BMI) is an easily obtained adiposity surrogate. However, there is variability in body composition and adipose tissue distribution between individuals with the same BMI, and there is controversy regarding the BMI associated with the lowest mortality risk.ObjectiveTo evaluate which of BMI, fat mass index (FMI), and waist-to-hip
Khan, Irfan +12 more
openaire +3 more sources
Surrogate Markers of Antiangiogenic Therapies [PDF]
The development of antiangiogenic compounds for the treatment of cancer has indicated a need for new clinical tools to evaluate their efficacy, to assess the optimal dose with minimal side-effects and to early select patients who might benefit from antiangiogenic therapies.
Boven, Epie +3 more
openaire +5 more sources
Inflammatory bowel disease (IBD) comprises two types of chronic intestinal disorders: Crohn’s disease and ulcerative colitis. In long-standing ulcerative colitis disease activity, histological persistent inflammation has been linked to an increased risk ...
Alina Ecaterina Jucan +12 more
doaj +1 more source
BackgroundHIV infection is associated with an increased risk of cardiovascular disease (CVD). Chronic low-grade immune activation is likely one of the driving mechanisms. This systematic review provides an overview of the evidence addressing the relation
Alinda G Vos +4 more
doaj +1 more source
Novel Surrogate Markers of CNS Inflammation in CSF in the Diagnosis of Autoimmune Encephalitis
Background: Autoimmune encephalitis (AE) is an important cause of refractory epilepsy, rapidly progressive cognitive decline, and unexplained movement disorders in adults.
Jocelyn X. Jiang +24 more
doaj +1 more source
Surrogate markers in HIV disease [PDF]
The use of surrogate markers in HIV disease is an attractive method of assessing the efficacy of new treatments more quickly than by using clinical end-points. The characteristics of an ideal surrogate marker and the theoretical dangers of extrapolating properties from one class of drug to another are described.
openaire +2 more sources

